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M ost experts agree that the current rate of rise of healthcare costs is unsustainable. The good news, however, is
that there is an emerging consensus among policymakers over
what needs to be done: realign financial incentives; reinvigo-
rate primary care; support more informed, patient-centered
decision making; develop a more robust evidence base of
comparative effectiveness; create standards for electronic
health records; invest in public health. In addition, many feel
that excessive tests, consultations, and procedures in the last
year of life contribute not only to higher costs but to
diminished quality of care. However, these concerns were
caricatured by conservative pundits and politicians, who
portrayed hospital ethics boards as “death panels” and
ultimately ensured that end-of life care was exiled from the
health care reform agenda.
Why focus on the end of life? Because about one-quarter of
Medicare spending occurs during the last year of life, because
there is considerable geographic variation in this spending,
and perhaps because, as Princeton bioethicist Peter Singer has
pointed out, most dying patients are elderly, and a slowing or
reversal of illness in an 85-year-old saves fewer life-years and
therefore produces less social utility than the same slowing or
reversal in a 35-year-old. (Readers interested in the debate over
utilitarian versus categorical ethics might like Michael Sandel’s
popular Harvard course, found at http://www.justiceharvard.
org/).
In this month’s issue of JGIM, several articles deal with the
care of patients who have serious medical conditions and who
may be nearing the end of life. In her Text and Context column,
Roslyn Weaver provides a touchstone for teaching the princi-
ples of clear communication, building safe and reliable
systems, and breaking bad news. As Weaver explains,
Dr. Trent, a principal character in LM Montgomery’s The Blue
Castle, mistakenly writes to his patient Valancy Stirling telling
her she has a fatal disease; paradoxically this frees her to
explore the more adventuresome side of her nature. Not
knowing this, Trent feels awful about the possible effects of
his error on Valancy, but shrugs off the miscommunication to
the other patient involved in the miscue, Jane Sterling. She
remains blissfully unaware of her terminal diagnosis through
the moment of her death two months later.
Blissful ignorance may be one of the reasons most patients
with terminal illness do not enroll in hospice early enough to
gain the full benefits. The spectrum of reasons is explored
systematically in an article by Vig et al., who report that some
reject opportunities to enroll in hospice because families
believe the patient “is not ready,” because patients fear
enrolling in hospice will close off other treatment options, and
because of concerns about disrupting continuity with their
current provider. Their inquiry does not stop with patients and
families, though. By sharing patient and family concerns with
hospice staff and end-of-life experts, the authors construct a
set of practical recommendations for helping patients make
fully informed decisions about end-of-life care.
Anyone who makes ward rounds knows there is no sorrier
situation than the patient facing serious or terminal illness
alone, bereft of family and friends. When the patient is
demented, delirious, or otherwise incompetent, the ethical
tensions intensify even as the terribleness of the situation
eases. When a patient cannot make decisions for him or herself
and has no ready surrogate, a guardian is appointed by the
courts. Bandy et al. describe the process of medical decision
making for incapacitated, hospitalized adults for whom court-
appointed guardians are requested. They find, not surprisingly,
that the legalistic structure erected to solve a social problem
has holes; many important medical decisions are made while
patients await appointment of a guardian.
JGIM values readers’ opinions on material published in the
journal. To submit a letter related to these articles or others, go
to http://www.jgimed.org/authors/.
Open Access: This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
Corresponding Author: Richard L. Kravitz, MD, MSPH, UC Davis
Division of General Medicine, 4150 V. Street, Suite 2400 PSSB,
Sacramento, CA 95817, USA (e-mail:rlkravitz@ucdavis.edu).Published online August 10, 2010
997
